A2026 HCPCS Level II code: Restrata minimatrix, 5 mg

A2026 is the HCPCS code for “Restrata minimatrix, 5 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.

Official description

A2026

Restrata minimatrix, 5 mg

HCPCS · United States

Medicare details

The indicators CMS publishes with A2026 in its October 2026 file. They describe Medicare’s handling, not another payer’s.

Medicare coverage
Carrier judgment
Medicare pricing
Physician fee schedule – Price established by carriers (e.g., not otherwise classified, individual determination, carrier discretion)
Type of service
Medical care
BETOS category
Ambulatory procedures - skin
Added
Apr 1, 2024

Where A2026 sits

  1. 1A codesAmbulance, supplies and miscellaneous
  2. 2Active code A2026Restrata minimatrix, 5 mg

Source and release

Data release
HCPCS Level II · October 2026
Effective date
Oct 1, 2026
Publisher
CMS

This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.

Frequently asked questions

What does HCPCS code A2026 mean?

A2026 is the HCPCS code for “Restrata minimatrix, 5 mg” in CMS’s HCPCS Level II October 2026 release.

Does Medicare cover A2026?

CMS lists A2026’s Medicare coverage as “Carrier judgment” and its pricing as “Physician fee schedule – Price established by carriers (e.g., not otherwise classified, individual determination, carrier discretion)”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.

Which HCPCS Level II release does this page use?

It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.